HRV & Health

Clinical studies on disease risk and health outcomes

American Heart Association 2022 Evidence: Works

Low SDNN Linked to Increased Mortality Risk

American Heart Association highlighted that 24-hour SDNN below 50ms is associated with significantly higher all-cause mortality risk, establishing a clinical threshold for concerning HRV levels.

Full study summary →
Translational Psychiatry 2025 Evidence: Works

HRV Reduced Across Most Mental Health Conditions

Umbrella review of meta-analyses confirmed that HRV is reduced in most mental disorders compared to healthy controls, with the strongest evidence for depression and anxiety disorders.

Full study summary →
Autonomic Neuroscience 2019 Evidence: Works

Low HRV Doubles Risk of Death in Cardiovascular Patients

Meta-analysis of cohort studies found that low HRV in cardiovascular disease patients more than doubled the risk of all-cause death and significantly increased cardiovascular event risk.

Full study summary →
Journal of the American Heart Association 2024 Evidence: Works

HRV Predicts Death Risk Even After Controlling for Genetics

Veteran twins study found that HRV and deceleration capacity predicted mortality risk independent of familial and genetic factors, suggesting HRV reflects modifiable health status.

Full study summary →
Psychophysiology 2024 Evidence: Works

HRV Shows Promise as Anxiety Treatment Response Biomarker

Review evaluated HRV as a potential biomarker for anxiety disorders, finding that HRV changes track with treatment response and may help predict who will benefit from specific interventions.

Full study summary →

Related Topics